DelNS1-2019-nCoV-RBD-OPT1

流感病毒载体新冠肺炎疫苗（万泰生物）

Report date: 2022/12/30 09:43:28

Base Information

Drug NameDelNS1-2019-nCoV-RBD-OPT1

Drug Alias Name鼻喷流感病毒载体新冠肺炎疫苗（万泰生物）鼻喷新冠疫苗（万泰生物）

ClassificationVaccines > Application > Prophylactic vaccineVaccines > Biological material > Viral vaccineVaccines > Development/production technology > Recombinant vector vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryVietnamPhilippinesSouth Africa +[6]

CombinationsNo

Global Highest StatusPhase 3 Clinical

Highest Status in ChinaPhase 2 Clinical

Originator CompaniesBeijing Wantai Biological Pharmacy Enterprise Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesBeijing Wantai Biological Pharmacy Enterprise Co Ltd

Inactive CompaniesThe University Of Hong Kong

Active IndicationsCoronavirus Disease 2019 (COVID-19)

Inactive IndicationsN/A

Other Information

ATC CodeN/A